Patent ID: 9636303
Date: 2017-05-02
CPC Classifications: A61K,A61P

Claim:
1. A pharmaceutical dosage form comprising: a pharmacologically active ingredient (A) selected from the group consisting of opioids; a physiologically acceptable polymer (B) selected from the group consisting of: (i) optionally cross-linked homopolymers of acrylic acid; (ii) optionally crosslinked copolymers of acrylic acid and C a polyalkylene oxide (C) having a weight average molecular weight of at least 200,000 g/mol, wherein the content of the polyalkylene oxide (C) is at least 20 wt.-%, based on the total weight of the dosage form; wherein the pharmacologically active ingredient (A) is present in a controlled-release matrix comprising the polymer (B) and the polyalkylene oxide (C); wherein the dosage form is thermoformed; and wherein the dosage form exhibits a breaking strength of at least 500 N.